Bank of New York Mellon’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$536K Buy
243,427
+9,476
+4% +$20.8K ﹤0.01% 3454
2025
Q1
$271K Sell
233,951
-9,425
-4% -$10.9K ﹤0.01% 3728
2024
Q4
$309K Buy
243,376
+463
+0.2% +$588 ﹤0.01% 3748
2024
Q3
$828K Sell
242,913
-53,241
-18% -$182K ﹤0.01% 3238
2024
Q2
$1.38M Buy
296,154
+11,332
+4% +$52.9K ﹤0.01% 2999
2024
Q1
$2.11M Sell
284,822
-28,440
-9% -$211K ﹤0.01% 2739
2023
Q4
$3.17M Sell
313,262
-972
-0.3% -$9.85K ﹤0.01% 2595
2023
Q3
$2.45M Buy
314,234
+39,076
+14% +$305K ﹤0.01% 2692
2023
Q2
$2.26M Buy
275,158
+11,491
+4% +$94.6K ﹤0.01% 2763
2023
Q1
$1.91M Buy
263,667
+6,882
+3% +$49.9K ﹤0.01% 2830
2022
Q4
$2.28M Buy
256,785
+3,494
+1% +$31K ﹤0.01% 2788
2022
Q3
$3.1M Buy
253,291
+20,327
+9% +$249K ﹤0.01% 2567
2022
Q2
$2.76M Sell
232,964
-55,914
-19% -$661K ﹤0.01% 2653
2022
Q1
$5.49M Buy
288,878
+1,060
+0.4% +$20.2K ﹤0.01% 2371
2021
Q4
$7.64M Sell
287,818
-13,643
-5% -$362K ﹤0.01% 2245
2021
Q3
$12.4M Buy
301,461
+28,207
+10% +$1.16M ﹤0.01% 2004
2021
Q2
$15.5M Buy
273,254
+19,212
+8% +$1.09M ﹤0.01% 1877
2021
Q1
$10.7M Sell
254,042
-25,952
-9% -$1.09M ﹤0.01% 2047
2020
Q4
$19.6M Buy
279,994
+30,215
+12% +$2.12M ﹤0.01% 1647
2020
Q3
$7.01M Sell
249,779
-66,582
-21% -$1.87M ﹤0.01% 2046
2020
Q2
$9.36M Buy
316,361
+60,383
+24% +$1.79M ﹤0.01% 1871
2020
Q1
$5.08M Sell
255,978
-3,866
-1% -$76.6K ﹤0.01% 2065
2019
Q4
$7.69M Buy
259,844
+9,461
+4% +$280K ﹤0.01% 2124
2019
Q3
$5.69M Buy
250,383
+42,580
+20% +$968K ﹤0.01% 2218
2019
Q2
$5.14M Sell
207,803
-12,304
-6% -$304K ﹤0.01% 2315
2019
Q1
$5.38M Buy
220,107
+19,605
+10% +$479K ﹤0.01% 2299
2018
Q4
$4.56M Buy
200,502
+1,651
+0.8% +$37.6K ﹤0.01% 2351
2018
Q3
$6.33M Buy
198,851
+5,579
+3% +$178K ﹤0.01% 2286
2018
Q2
$6.93M Sell
193,272
-10,683
-5% -$383K ﹤0.01% 2217
2018
Q1
$6.76M Buy
203,955
+44,654
+28% +$1.48M ﹤0.01% 2189
2017
Q4
$4.9M Sell
159,301
-8,914
-5% -$274K ﹤0.01% 2367
2017
Q3
$4.04M Buy
168,215
+26,093
+18% +$627K ﹤0.01% 2446
2017
Q2
$2.39M Buy
142,122
+78,632
+124% +$1.32M ﹤0.01% 2747
2017
Q1
$1.42M Buy
63,490
+22,061
+53% +$493K ﹤0.01% 3053
2016
Q4
$672K Buy
41,429
+2,878
+7% +$46.7K ﹤0.01% 3451
2016
Q3
$520K Buy
38,551
+10,812
+39% +$146K ﹤0.01% 3514
2016
Q2
$677K Buy
27,739
+10,514
+61% +$257K ﹤0.01% 3382
2016
Q1
$595K Buy
+17,225
New +$595K ﹤0.01% 3355